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Xenopus laevis FGF16 activates the expression of genes 
coding for the transcription factors Sp5 and Sp5l
MICHAEL ELSY, ABIGAIL ROWBOTHAM, HANNAH LORD, HARRY V. ISAACS and MARY E. POWNALL*
Biology Department, University of York, UK
ABSTRACT  Fibroblast growth factors (FGFs) comprise a family of signalling molecules with es-
sential roles in early embryonic development across animal species. The role of FGFs in mesoderm 
formation and patterning in Xenopus has been particularly well studied. However, little is known 
about FGF16 in Xenopus. Using in situ hybridisation, we uncover the expression pattern of FGF16 
during early Xenopus laevis development, which has not been previously described.  We show 
that the zygotic expression of FGF16 is activated in the mesoderm of the early gastrula as a ring 
around the blastopore, with its first accumulation at the dorsal side of the embryo. Later, FGF16 
expression is found in the otic vesicle, the branchial arches and the anterior pituitary, as well as in 
the chordal neural hinge region of the tailbud. In addition, we show that FGF16 can activate the 
MAPK pathway and expression of sp5 and sp5l. Like FGF16, sp5 is expressed in the otic vesicle 
and the branchial arches, with all three of these genes being expressed in the tailbud.  These data 
provide evidence that FGF16 is present in the early mesoderm and can activate the expression of 
developmentally important transcription factors. 
KEY WORDS: mesoderm, secreted growth factor, cell signaling, transcriptional regulation
Introduction
Fibroblast growth factors (FGFs) are small polypeptide signal-
ling molecules defined by a conserved 120-140 amino acid core 
and their high affinity for heparan sulfate (Goetz & Mohammadi, 
2013). FGFs signal through a family of tyrosine kinase receptors 
(Zhang et al., 2006) coded for by four distinct FGF receptor (FGFR) 
genes that can be differentially spliced (Johnson et al., 1991). 
This, together with multiple distinct ligands, leads to the impres-
sive complexity underlying FGF signalling. Activation of the FGF 
pathway involves the formation of a tripartite signalling complex 
of FGF ligand, heparan sulfate, and FGFR (Turnbull et al., 2001). 
Receptor dimerization activates one of four downstream signal 
transduction pathways: mitogen-activated protein kinase (MAPK), 
phospholipase-C g1 (PLC-g1), phosphatidylinositol 3-kinase (PI-3 
kinase) or Janus kinase/signal transducer and activator of tran-
scription (Jak/STAT) (Dorey & Amaya, 2010; Ornitz & Itoh, 2015). 
The autophosphorylation of tyrosine residues within the FGFR 
intracellular domain results in the phosphorylation of FRS2a, a 
kinase substrate constitutively associated with the FGFR, and the 
subsequent recruitment of the GRB2 adapter protein. GRB2 then 
recruits the guanine nucleotide exchange factor, son of sevenless 
(SOS) (Ong et al., 2000). For the activation of the MAPK path-
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way, SOS activates Ras GTPase, in turn activating Raf (a MAP 
kinase kinase kinase), Mek (a MAP kinase kinase) and MAPK 
ERK in a cascade of phosphorylation events. Phosphorylated 
ERK translocates to the nucleus and modifies the activity of Ets 
family transcription factors, resulting in effects on gene expression 
downstream of FGF signalling (Randi et al., 2009).
There are 22 members of the FGF family, which are divided into 
subfamilies: paracrine FGFs (FGF1-10, 16-18, 20, 22), intracellular 
FGFs (FGF11-14), and endocrine FGFs (FGF15/19, 21,23). Most 
FGFs require N-terminal signal peptides for secretion (Käll et al., 
2004). However, the FGF9 group, including FGF 9, 16 and 20, 
lack cleavable signal peptides (Itoh & Ornitz, 2004). The secre-
tion of these FGFs relies upon un-cleavable bipartite signals in 
the N-terminal and central hydrophobic region (Miyakawa et al., 
1999; Revest et al., 2000), with secretion, nonetheless, requir-
ing the Golgi and the endoplasmic reticulum (ER) (Miyakawa & 
Imamura,2003). 
FGF16 was originally identified in the rat heart (Miyake et al., 
1998) and has known cardiogenic and cardioprotective roles 
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(Hotta et al., 2008; Lu et al., 2008; Wang et al., 2015), as well as 
roles in the development of the chick inner ear (Chapman et al., 
2006; Olaya-Sánchez et al., 2017), the formation of pectoral fin 
buds in zebrafish (Nomura et al., 2006), and the specification of 
GABAergic neurons and oligodendrocytes in the zebrafish forebrain 
(Miyake et al., 2014). RNA-seq analysis shows FGF16 is expressed 
during gastrulation in X.laevis and X.tropicalis embryos (Owens 
et al., 2016; Session et al., 2016). For example, FGF16.L expres-
sion peaks at NF stage 12 and remains high during neurulation 
in X.laevis, before decreasing in early and late tailbud stages, 
whereas FGF16.S is expressed at a much lower level, and is not 
expressed after gastrulation (Owens et al., 2016; Session et al., 
2016). Attempts to clone FGF16 from Xenopus tropicalis were 
unsuccessful (Lea et al., 2009), and the spatial expression pattern 
of FGF16 has not been previously described during the develop-
ment of X.tropicalis or X.laevis. 
Transcription downstream of FGF signalling has been investi-
gated in Xenopus mesoderm (Branney et al., 2009) and the genetic 
targets identified included sp5 and sp5-like (sp5l), which code for 
zinc finger transcription factors (Ossipova et al., 2002). Despite 
this finding in Xenopus, most of the knowledge linking sp5 and 
sp5l to a role downstream of FGF signalling comes from work in 
zebrafish. Sp5 (bts1) expression in the neural plate was found to 
be strongly reduced in response to FGF inhibition (Tallafub et al., 
2001), and sp5l expression in the mesoderm is also dependent 
on the presence of FGF signals (Zhao et al., 2003; Weidinger et 
al., 2005). Consistent with a role downstream of FGF signalling, 
Sp5l can posteriorize the neuroectoderm, as it positively regulates 
posterior neuroectodermal marker hoxb1b and represses the an-
terior markers fez and otx1 in whole embryos (Zhao et al., 2003). 
These studies support the idea that sp5 and sp5l are downstream 
targets of FGF signalling in zebrafish. Here we describe the clon-
ing and characterisation of X. laevis FGF16 and identify sp5 and 
sp5l as transcriptional targets of FGF signalling during amphibian 
development.
Results
Cloning of Xenopus laevis FGF16
The predicted sequence for X. laevis FGF16 on chromosome 8L 
encodes a 202 amino acid protein that is highly homologous (86% 
amino acid identity) to human FGF16. The genomic organisation 
shows syntenic regions in Xenopus and human chromosomes, 
providing confidence that the sequence (GenBank Accession No. 
XM_018229763.1) encodes for the full-length X. laevis FGF16.L 
protein. PCR primers were designed against the predicted cDNA 
Fig. 1. Phylogenetic analysis of predicted FGF families. FGF family 
groupings are represented by brackets. Bold red brackets indicate the FGF9 
subfamily: FGF9, FGF16 and FGF20. Protein sequences were aligned using 
MUSCLE. The evolutionary history was inferred by using the Maximum 
Likelihood method based on the Jones-Taylor-Thornton (JTT) matrix-based 
model (Jones et al., 1992). The percentage of trees in which the associ-
ated taxa clustered together is shown next to the branches (500 bootstrap 
support). The tree is drawn to scale, with branch lengths measured in the 
number of substitutions per site. Labels are as follows: xl = Xenopus laevis; 
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sequence (Table 1) and a 609bp product was amplified 
from cDNA derived from X. laevis embryos (NF stage 11).
Analysis of gene expression at gastrula stages
DIG-labelled antisense RNA probes were used for in situ 
hybridisation analysis of FGF16 gene expression (Figs 2 
and 3). FGF16 expression is restricted to the dorsal blas-
topore lip during stage 10, and as gastrulation proceeds, 
the expression of FGF16 extends to the mesoderm around 
the whole of the blastopore by stage 11 and is seen in 
the posterior mesoderm around the closed blastopore at 
stage 12. We have analysed the genes sp5 and sp5l as 
potential targets of FGF signalling; at gastrula stages, both 
sp5 and sp5l have much wider expression domains than 
FGF16 (Fig. 2 D-E and G-H). At NF stage 12, FGF16, sp5 
and sp5l are all co-expressed in the posterior mesoderm 
around the closed blastopore (Fig. 2 C, F, and I; arrow).
Analysis of FGF16 at later stages
 Using in situ hybridisation we have found that FGF16 
is expressed in the posterior mesoderm of early tailbud 
embryos, as well as the otic vesicle and anterior pituitary 
(Fig. 3A,B). FGF16 expression is detected in the branchial 
arches and mesoderm of later tailbuds (Fig. 3C,D). In the 
tail, FGF16 expression is restricted to the chordoneural 
hinge and the posterior wall of the neuroenteric canal 
(Fig. 3D) (Tucker & Slack, 1995). FGF16 is expressed 
in the anterior pituitary during early tailbud development 
(Fig. 3B) in X.laevis, consistent with findings in zebrafish 
(Miyake et al., 2014).
Analysis of sp5 and sp5l in X.tropicalis embryos
The expression of sp5 and sp5l has been described in 
is only expressed in the tailbud (Fig. 4 L-M). These data reveal 
that the expression patterns of sp5 and sp5l are distinct throughout 
development and have some overlapping regions of expression to 
FGF16, as well as other FGF ligands (Lea et al., 2009).
Analysis of FGF16 signal transduction
The N-terminus of most FGF ligands has a region of high 
Fig. 2. Expression analysis FGF16, sp5 and sp5l in gastrula stage X.laevis em-
bryos. In situ hybridisation analysis was used to detect transcripts for FGF16 (A-C), 
sp5 (D-F), and sp5l (G-I) during gastrulation. Stages 10 posterior/vegetal (A, D, G) 
11 posterior/vegetal view (B, E, H) and 12 (C, F, I) posterior view. Arrow indicates 
dorsal blastopore lip in all panels.
Fig. 3. Developmental expression pattern of FGF16 in 
X.laevis embryos. In situ hybridisation analysis was used to 
detect transcripts for FGF16 at several developmental stages in 
X. laevis embryos. At least 15 embryos were analysed at each 
stage (st). (A,B) St 26, lateral and anterior views respectively. 
(C,D) St 35, lateral and magnified lateral tail views respectively. 
Abbreviations are as follows: anterior pituitary (ap), otic vesicle 
(ov), plate mesoderm (pm), branchial arches (ba) and chordo-
neural hinge (cnh).
X. laevis, but not in X. tropicalis, which we report here (Ossipova 
et al., 2002). Sp5 expression in X. tropicalis at neurula stage 18 is 
found in the midbrain and the neural crest, as well as being faintly 
expressed towards the posterior of the embryo (Fig. 4 A-B). Sp5l is 
expressed along the neural folds and in the posterior region of the 
embryo (Fig. 4 D-F) and also expressed in migrating crest cells in 









has clear expression in the head, including the forebrain, 
midbrain, midbrain-hindbrain barrier (MHB) and otic 
placode, but also in a small domain in the tailbud (Fig. 4 
C). Sp5l at stage 26 is expressed in the posterior of the 
neural tube and the tailbud, but also in a small domain 
in the head (Fig. 4G-H). At stage 31, sp5 expression in 
X. tropicalis is found in the forebrain, midbrain, MHB, 
branchial arches (BA) 1-4 as previously described in 
X.laevis (Square et al., 2015), and dorsal to the otic 
vesicles and in the tailbud (Fig. 4 I-K). At this stage, sp5l 
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hydrophobicity called a signal sequence that is required for 
secretion. However, vertebrate orthologues of FGF9, FGF16 
and FGF20 have divergent N-termini and lack a signal sequence 
(Miyakawa & Imamura, 2003). These FGF ligands are char-
acterised by conserved mid-regions and C-termini that allow 
secretion (Katoh & Katoh, 2005). This is shown in Fig. 5, where 
the low N-terminus hydrophobicity for the FGF9 subfamily is 
compared to FGF4 (Fig. 5A, compared to Fig. 5 B-D). The 
FGF9 subfamily members contain an internal hydrophobicity 
region, which likely aids the proteins’ secretion out of the cell 
(Miyakawa & Imamura, 2003). 
The animal cap is a source of pluripotent cells which devel-
ops into atypical epidermis in the absence of additional signals 
(Green, 1999). Upon treatment with growth factors, including 
FGFs, the animal cap can be diverted from this epidermal fate 
to differentiate into different tissue types, such as mesoderm 
(Kimelman & Kirschner, 1987; Slack et al., 1987). Therefore, this 
approach provides a robust biological assay for FGF16 activity 
(Fig. 6). ERK, also known as MAPK, is the effector of the Ras-
Raf-MEK-MAPK signalling pathway. The diphosphorylation of 
ERK (dp-ERK) indicates that FGF16 can strongly activate the 
MAPK signalling pathway in animal caps (Fig. 6A). FGF16 is 
shown to affect cell behaviour, due to untreated animal caps 
forming round balls of atypical epidermis after 3 days (Fig. 6B), 
whereas those expressing FGF16 form vesicles of mesoderm 
including blood, mesothelium and muscle (Fig. 6C).
FGF signalling activates sp5 and sp5l expression
Previous research suggests that X.laevis sp5 and sp5l are 
positively regulated targets of FGF signalling (Branney et al., 
2009; Park et al., 2013). To further test this possibility, the ef-
fect of increasing FGF signalling on sp5 and sp5l expression 
was investigated. X. laevis embryos were injected with 10pg 
of mRNA coding for FGF4, known to be a potent mesoderm 
inducer (Isaacs et al., 1994), or 50pg of mRNA coding for 
FGF16. RT-PCR was performed on stage 12 whole embryos 
and animal cap explants from injected embryos compared to 
uninjected controls. Expression of sp5, sp5l and known FGF 
targets, xbra, cdx4, and gr1, was analysed. Both FGF4 and 
FGF16 injection induced the FGF target genes as well as sp5 
and sp5l (Fig. 6D). 
Collectively these results show that sp5 and sp5l are down-
stream targets of FGF signalling, with the identification of FGF16 
as a novel ligand that has mesoderm inducing activity.
Fig. 4. Developmental expression pattern of sp5 and sp5l in X.tropicalis 
embryos. Analysis of sp5 and sp5l expression by whole-mount in situ 
hybridisation of X. tropicalis embryos; at least 15 embryos were analysed 
at each developmental stage for each probe. (A,B) sp5 expression at 
neurula st18, lateral and dorsal views respectively. White triangles show 
faint expression in the posterior region of the embryos. (C) sp5 expression 
at tailbud st25, lateral view. (D,E) sp5l expression at neurula st18, lateral 
and dorsal views respectively. (F) Transverse section of the embryo in (E) at the level of the dashed line. (G) sp5l expression at tailbud st26, lateral 
view. (H) Transverse section of embryo in (G) at the level of the dashed line. (I-K) sp5 expression at tailbud st31, lateral view. (L,M) sp5l expression 
at tailbud st31, lateral view. Abbreviations: Midbrain (MB), Neural crest (NC), Forebrain (FB), Otic placode (OP), Midbrain Hindbrain Boundary (MHB), 
Migrating crest cells (MCC) Neural fold (NF), Neural tube (NT), Branchial Arches (BA), Otic Vesicle (OV).
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Discussion
FGF16 signal transduction
In this study, FGF16 was found to be able to activate MAPK 
signalling and induce mesoderm. The Ras-Raf-MEK-ERK (MAPK)- 
pathway has a well-defined role in regulating mesoderm induction 
in response to FGF signalling (Cornell & Kimelman, 1994; LaBonne 
et al., 1995; LaBonne & Whitman, 1994; Umbhauer et al., 1995; 
Whitman & Melton, 1992). FGF16 has also been shown to signal 
through the MAPK pathway in human ovarian cancer cells (Basu 
et al., 2014), and here we demonstrate FGF16-mediated MAPK 
activity to be observed in the mesoderm induction assay. The 
role of FGF9, FGF16 and FGF20 in mesoderm induction has not 
been well characterised. However, FGF9/16/20, an ancestral form 
of the vertebrate FGF9 subfamily, has been shown to induce 
mesenchyme formation in Ciona intestinalis embryos (Imai et al., 
2002; Tokuoka et al., 2004). The presence and activity of this class 
of FGF ligand in a distant chordate relative supports the notion 
that FG9/16/20 is a conserved factor for mesoderm specification 
(Davidson et al., 2006). Furthermore, an RNA-seq screen of X. 
laevis gastrula expression in dorsal and ventral lip tissue identi-
fied FGF16.S and FGF16.L as having moderate positive Pearson 
correlation coefficients of 0.48 and 0.25 respectively to chordin, 
indicating the two genes may share transcriptional regulation 
mechanisms and that FGF16 may be involved in dorsal-ventral 
patterning (Ding et al., 2017).
The paracrine FGFs signal through the four different FGFRs, 
triggering multiple downstream signalling pathways to result in 
the regulation of transcription factors required for controlling many 
different developmental processes, such as mesoderm induction 
(reviewed in Ornitz and Itoh, 2015). The alternative splicing of 
FGFR receptors greatly increases ligand binding specificity, par-
ticularly through the generation of two isoforms of Ig-like domain 
III (epithelial b splice forms or mesenchymal c splice forms) (Yeh 
et al., 2003). FGF9 subfamily members have similar FGFR binding 
affinities (Zhang et al., 2006). For example, mouse homologue 
FGF9 preferentially binds to FGFR2 and FGFR3 c splice variants, 
displaying greatest affinity for FGFR3, but does not bind FGFR1 or 
FGFR4 (Hecht et al., 1995; Ornitz et al., 1996; Santos-Ocampo et 
al., 1996). Zhang et al., (2006) confirm a strong binding of FGF9, 
16 and 20 to FGFR3c, FGFR3b and FGFR2c when cataloguing 
the receptor binding of all FGF ligands in the murine Baf3 cell 
line. FGF20 binding matches the other FGF9 subfamily members, 
although it has higher affinity for FGFR2b (Zhang et al., 2006). 
Murine FGF16 appears to have the highest affinity for FGFR3c, 
followed by FGFR3b and FGFR2c, but does not bind to FGFR2b 
or FGFR1b and only weakly binds FGFR4 (Zhang et al., 2006). 
The same binding profile for FGF16 is revealed using the Baf3 
assay, with very weak FGFR1c affinity demonstrated (Lavine et 
al., 2005; Lu et al., 2008). Furthermore, FGF16-mediated inva-
sion in a human ovarian cancer model persists upon addition 
of a selective FGFR1 inhibitor, PD 173074 (Mohammadi et al., 
1998), confirming FGF16 to not preferentially signal through 
FGFR1 (Basu et al., 2014). Konishi et al., (2000) also report that 
FGF16 only binds the extracellular domain of FGFR4, showing no 
affinity for FGFR1c or FGFR2c, during embryonic brown adipose 
tissue development, suggesting altered FGF16 ligand specificity 
for different developmental stages or tissue types. 
FGF16 secretion
Phylogenetic analysis of sequences obtained from Xenbase 
matched the consensus arrangement of the 22 FGF members into 
Fig. 5. Hydrophobicity plots for 
FGF9 family. Kyte and Doolittle 
hydrophobicity plots for (A) FGF4 
and FGF9 sub-family members, (B) 
FGF9, (C) FGF16, and (D) FGF20. 
Scores above 0 (represented by the 
dotted line) indicate hydrophobic 
amino acids; sites of high hydro-
phobicity are depicted as shaded 
areas. FGF4 has a “classic” signal 
sequence (SS) for co-translational 
secretion, but the members of the 
FGF9 subfamily have an internal 
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Compared to its relatives, sp5 is unique having two paralogs in 
the Xenopus and teleost lineages (Ossipova et al., 2002; Zhao 
et al., 2003, Tallafub et al., 2001), whilst there is only one locus 
present in mammals (Harrison et al., 2000). Phylogeny suggests 
that these genes were duplicated from the same ancestor, but 
one copy was lost subsequently from the mammalian and bird 
lineages in evolution (Zhao et al., 2003; Pei and Grishin, 2015). 
In Xenopus these paralogs are referred to as sp5 and sp5l.
The Sp1-like transcription factors are a family of proteins with 
important regulatory roles in development (Reviewed by Zhao and 
Meng., 2005). The family comprises of Sp1 along with a number 
of structurally similar transcription factors which share defining 
features such as a triple C2H2 zinc finger domain in the C-terminal 
region and a preceding buttonhead (Btd) box (Reviewed by Zhao 
and Meng, 2005; Ossipova et al., 2002). Sp1-like transcription 
factors have been identified in a variety of species, including 
Xenopus, which has 10 members (Presnell et al., 2015). These 
transcription factors regulate the expression of target genes by 
acting as transcriptional activators or repressors in a context-
dependent manner (Fujimura et al., 2007; Hagen et al., 1995; 
Birnbaum et al., 1995; Phan et al., 2004; Majello et al., 1997). 
The DNA binding specificity of these factors is similar across the 
family, with the conserved triple zinc finger domain recognising 
GC-rich sequences in the promoter regions of genes (Kadonaga 
et al., 1987). Differences in key residues of the zinc finger motifs 
modulate this DNA binding specificity between family members 
(Reviewed by Kaczynski et al., 2003). Although this family shares 
commonality in structure and DNA binding, different members 
appear to play distinct roles in embryonic development, which is 
demonstrated by their dynamic expression patterns (Reviewed 
by Zhao and Meng, 2005). In situ hybridisation in Xenopus spe-
cies showed that sp5 and sp5l have distinct expression patterns 
throughout development.
Sp5 and sp5l clearly have differential expression patterns 
throughout development, indicating they likely have different 
functional roles. Presence of sp5 in the neural crest and related 
structures, the branchial arches and otic vesicle, suggests a role 
in neural crest formation. Supporting this hypothesis, knockdown 
of sp5 results in defective neural crest structures and sp5 over-
expression or loss causes up- or down-regulation of neural crest 
markers sox10, sox9 and slug (Park et al., 2013). Sp5l expression 
is similar to posterior factors cdx4 and hoxA7, with expression in 
the posterior neural tube and tailbud (Northrop and Kimelman, 
1993; Pownall et al., 1998) suggesting a role in posterior patterning.
In comparison to Xenopus, murine Sp5 is expressed in the 
primitive streak throughout gastrulation and is subsequently in 
Fig. 6. FGF16 activates the MAPK pathway and activates sp5 and sp5l expression. 
(A) Western blot to detect dpERK in uninjected control animal caps compared and animal 
caps injected with 50 pg of mRNA coding for FGF16 mRNA. Antibodies to diphospho-ERK 
(dp-ERK) and total ERK were incubated on the same blot sequentially after stripping. (B) 
Control animal caps after 3 days culture. (C) Animal caps expressing FGF16 from sibling 
embryos to those shown in (B). (D) RT-PCR on cDNA derived from whole embryos at 
stage 12 and on animal cap explants cultured to stage 12 that were either uninjected 
control explants or explants expressing FGF4 or FGF16. Expression of known FGF targets, 
xbra (27 cycles), egr1 (27 cycles) and cdx4 (27 cycles), as well as sp5 (25 cycles), sp5l 
and rpl8 loading control. Water, in which H
2
O replaced cDNA, and - RT, where no reverse 
transcriptase was used, functioned as negative controls.
7 different subfamilies (Fig. 1) (Itoh & Ornitz, 2004). 
FGF9 subfamily members are highly homologous 
in structure and have similar receptor binding 
sites (Itoh & Ornitz, 2004; Zhang et al., 2006). For 
example, they have a conserved C-terminus and 
central hydrophobic region, which is required for 
secretion (Miyakawa & Imamura, 2003). Despite 
this knowledge, the mechanism of FGF16 secretion 
remains to be elucidated. 
Most FGFs require N-terminal signal peptides for 
secretion (Kapp et al., 2009). However, FGF1, FGF2, 
FGF9, FGF16 and FGF20 lack cleavable signal 
peptides. FGF1 and 2 can be released in response 
to damage via an ER-Golgi independent exocytotic 
secretory pathway (Itoh & Ornitz, 2004; Mignatti 
et al., 1992). Instead, FGF2 directly translocates 
across the plasma membrane for secretion (Nickel, 
2010; Zehe et al., 2006). Although FGF9 subfamily 
members are secreted, they reply upon uncleav-
able bipartite signals including the N-terminal and 
central hydrophobic region (Miyakawa et al., 1999; 
Revest et al., 2000). Interestingly, Miyakawa & 
Imamura (2003) showed that FGF16 is secreted by 
a process requiring the endoplasmic reticulum and 
Golgi; retrograde Golgi transport of FGF16 was first 
inhibited by using brefeldin A and N-glycosylation of 
the N-terminus was separately observed, indicat-
ing that FGF16 must have progressed to the ER 
for processing.
sp5 and sp5l expression and regulation
Our data indicate that sp5 and sp5l are candi-
dates for regulation by FGF16. There is overlap of 
their expression domains in the early mesoderm 
and FGF16 is able to activate the expression of 
both sp5 and sp5l in a mesoderm induction assay. 
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the midbrain, MHB, neural tube, somites, pharyngeal region 
and the tailbud (Harrison et al., 2000). Xenopus sp5 and sp5l 
recapitulate different aspects of mammalian Sp5 patterning and 
possibly function. Murine Sp5 and Xenopus sp5 share expression 
in the midbrain, MHB and pharyngeal region, whereas Xenopus 
sp5l and murine Sp5 share expression in the neural tube. Both 
Xenopus paralogs are expressed in the tailbud, like murine Sp5. 
Mammals do not possess Sp5l, hence mammalian Sp5 may 
perform the roles of both Xenopus sp5 and sp5l. This suggests 
a divergence of function in Xenopus Sp5 and Sp5l proteins after 
their duplication event, whilst mammals lost their Sp5l locus and 
Sp5 retained all function.
Materials and Methods
Embryos
X. laevis and Xenopus tropicalis embryos were obtained using artificial 
fertilisation. X.laevis embryos were microinjected in 0.3 x normal amphib-
ian medium (NAM) + 5% ficoll and cultured in 0.1 x NAM between tem-
peratures of 14°C – 23°C. X.tropicalis embryos were cultured in MRS/20 
between temperatures 20°C – 24°C. All embryos were staged according 
to Nieuwkoop & Faber (1967).
Multiple sequence alignments for FGF16
Xenbase was used to obtain the available X. laevis FGF amino acid 
and coding sequences (Karimi et al., 2018). BLAST (Basic Local Align-
ment Search Tool) searches identified the Gallus gallus (chick) and Homo 
sapiens (human) FGF sequences (Priyam et al., 2015). X. laevis FGF16 
is unavailable on Xenbase; the human FGF16 amino acid sequence was 
used to identify the X. laevis FGF16 genomic sequence. The apparent 
evolutionary relationship between all members of the X. laevis, Gallus gal-
lus and Homo sapiens FGF families was examined. A maximum-likelihood 
phylogenetic tree was created using Mega7 software and alignments 
performed for amino acid sequences using MUSCLE (Edgar, 2004; Kumar 
et al., 2016). FGF9, FGF16 and FGF20 alignments were created using 
GeneDoc software (Nicholas, 1997).
Cloning of Xenopus laevis FGF16
RNA was extracted from stage 11, 17, 20 and 25 X. laevis embryos 
via Trizol (Invitrogen) extraction and the Zymo-SpinTM IC column RNA 
preparation procedure (Zymo Research), according to the manufacturer’s 
instructions. Extracted RNA was used to generate cDNA using the Super-
Script® IV First-Strand Synthesis System (Invitrogen). Stage 11 cDNA was 
amplified by polymerase chain reaction (PCR) with GoTaq® Green Master 
Mix (Promega) and specific FGF16 primers (Table 1). PCR products were 
ligated into the pGEM-T Easy DNA vector (Promega), and subsequently 
subcloned into pCS2+ using EcoR1.
In vitro transcription of DIG-labelled probes
pGEM-FGF16 was linearized using Sph1; pCS107 containing Sp5 
(GenBank Accession: AAH62500) using NcoI, and pCS107 containing 
Sp5l (GenBank Accession: AAI54679) using HindIII before transcription 
using the DIG RNA Labelling Kit (Roche). T7 RNA polymerase was used 
for sp5 and sp5l DIG transcription and SP6 RNA polymerase for FGF16.
In situ hybridisation
Embryos were collected at the appropriate stages and fixed in MEMFA 
(0.1M MOPS, 2mM EDTA, 1mM MgSO4, 3.7% formaldehyde). In situ hy-
bridisations were performed following the procedure described in Fisher 
et al., (2002). Hybridisation was carried out overnight at 60°C with 1mg/
ml of FGF8- and FGF16- DIG probes. Embryos were then incubated 
overnight at 4°C with a 1/2000 dilution of affinity-purified sheep anti-DIG 
antibody coupled to alkaline phosphatase (AP) in blocking solution. Colour 
reactions were subsequently performed overnight using the BM purple 
precipitating AP detection system (Roche). Pigment was removed using 
5% H2O2 solution in PBS.
Photography
Images were taken using the SPOT insight 4 MP CCD colour camera 
attached to a Leica MZFLIII microscope.
Generating synthetic mRNA
pCS2+-FGF16 was linearized using NotI and Capped FGF16 mRNA 
was generated using the mMessage mMachine SP6 transcription kit (In-
vitrogen), following the manufacturer’s instructions. 
Western blot analysis
X. laevis animal cap explants were dissected at NF stage 8 and cultured 
until NF stage 12 when they were collected and homogenised in sample 
buffer and centrifuged (Keenan et al., 2006). Supernates were loaded 
onto an acrylamide gel for SDS-PAGE and protein electro-transferred onto 
Immobilon-P PDVF membranes (Millipore). Membranes were blocked in 5% 
milk/PBSAT. Primary antibody dilutions were: mouse a-dp-ERK (Sigma), 
1/4000; a-total-ERK, 1/500,000; a-pP38, 1/2000; a-pAKT, 1/5000. Sec-
ondary antibody dilutions were: dpERK a-mouse HRP, 1/4000; total ERK, 
pP38 and pAKT a-rabbit, 1/2000. BM chemiluminescence blotting substrate 
(Roche) was used for peroxidase activity detection.
Semi-quantitative RT-PCR
5 embryos, or 10 animal cap (ectodermal) explants, were flash-frozen 
on dry ice, and RNA was extracted using TRIzol Reagent® (Sigma). cDNA 
was synthesised from 1mg of total RNA using SuperScript® IV Reverse 
Transcriptase (Invitrogen). In short, total RNA was incubated for 5mins 
at 65℃ with 50mM random hexamer primers and then incubated with 
reverse transcriptase at 23℃ for 10mins, 55℃ for 10mins and 80℃ for 
10mins. To check for any genomic contamination, control RNA was also 
processed without reverse transcriptase. PCR amplification was performed 
using primers in Table 1, including those for ribosomal protein L8 (rpl8) as 
a ubiquitously expressed loading control. 
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